Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone in pediatric ALI/ARDS
NCT01274260Phase 2Unknown
- Sponsor
- University of Tennessee
- Start
- Oct 2010
- Primary completion
- Jan 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone injection in acute respiratory distress syndrome (ARDS), acute lung injury (ALI), sponsored by University of Tennessee. Status: unknown.
02
Drugs
methylprednisolone injection
03
Conditions
acute respiratory distress syndrome (ARDS)acute lung injury (ALI)
Beyond the preview
Go deeper on NCT01274260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01274260.